Robert Jenkins

Array ( [id] => 12117373 [patent_doc_number] => 20180000959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-04 [patent_title] => 'TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 15/652947 [patent_app_country] => US [patent_app_date] => 2017-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 45524 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15652947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12001797 [patent_doc_number] => 20170305952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/644171 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16122 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15644171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14963073 [patent_doc_number] => 20190309014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-10 [patent_title] => PROCESS FOR PREPARATION OF ICATIBANT ACETATE [patent_app_type] => utility [patent_app_number] => 16/314889 [patent_app_country] => US [patent_app_date] => 2017-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5209 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14467747 [patent_doc_number] => 20190185516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-20 [patent_title] => BACKBONE CYCLIZED INHIBITORY PEPTIDES OF MYELOID DIFFERENTIATION FACTOR 88 (MYD88) [patent_app_type] => utility [patent_app_number] => 16/307841 [patent_app_country] => US [patent_app_date] => 2017-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14607 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16564255 [patent_doc_number] => 10889613 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-12 [patent_title] => Solid phase peptide synthesis processes and associated systems [patent_app_type] => utility [patent_app_number] => 15/602056 [patent_app_country] => US [patent_app_date] => 2017-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 94 [patent_no_of_words] => 24937 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15602056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12029550 [patent_doc_number] => 20170319650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'MASPIN-BASED INHIBITION OF OSTEOCLAST ACTIVITY AND PROMOTION OF BONE FORMATION' [patent_app_type] => utility [patent_app_number] => 15/588179 [patent_app_country] => US [patent_app_date] => 2017-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9297 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15588179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13263301 [patent_doc_number] => 10143720 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-12-04 [patent_title] => Modulation of hepatitis B virus cccDNA transcription [patent_app_type] => utility [patent_app_number] => 15/483711 [patent_app_country] => US [patent_app_date] => 2017-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 15754 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15483711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11756104 [patent_doc_number] => 20170202970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 15/477721 [patent_app_country] => US [patent_app_date] => 2017-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 72627 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15477721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11979312 [patent_doc_number] => 20170283467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'PROGRAMMABLE POLYPEPTIDE AND NUCLEIC ACID NANOPARTICLES' [patent_app_type] => utility [patent_app_number] => 15/476083 [patent_app_country] => US [patent_app_date] => 2017-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 9036 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14820953 [patent_doc_number] => 10407468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-10 [patent_title] => Methods for synthesizing a4b7 peptide antagonists [patent_app_type] => utility [patent_app_number] => 15/467810 [patent_app_country] => US [patent_app_date] => 2017-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 33986 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15467810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11729295 [patent_doc_number] => 20170190737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES' [patent_app_type] => utility [patent_app_number] => 15/465492 [patent_app_country] => US [patent_app_date] => 2017-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80530 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15465492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14116915 [patent_doc_number] => 10245298 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-02 [patent_title] => Compositions and methods for treating fibrosis [patent_app_type] => utility [patent_app_number] => 15/460151 [patent_app_country] => US [patent_app_date] => 2017-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 35 [patent_no_of_words] => 25477 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15460151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13458069 [patent_doc_number] => 20180280577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => PEPTIDE HAVING TITANIUM-BINDING ABILITY [patent_app_type] => utility [patent_app_number] => 15/545679 [patent_app_country] => US [patent_app_date] => 2017-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7445 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14818313 [patent_doc_number] => 10406142 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-10 [patent_title] => Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom [patent_app_type] => utility [patent_app_number] => 15/450812 [patent_app_country] => US [patent_app_date] => 2017-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15492 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15450812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12138219 [patent_doc_number] => 20180016301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-18 [patent_title] => 'Synthesis of Beta-Arrestin Effectors' [patent_app_type] => utility [patent_app_number] => 15/436214 [patent_app_country] => US [patent_app_date] => 2017-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15120 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15436214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11954779 [patent_doc_number] => 20170258929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-14 [patent_title] => 'CANCER TREATMENT COMBINATION COMPOSITIONS, METHODS AND USES' [patent_app_type] => utility [patent_app_number] => 15/430123 [patent_app_country] => US [patent_app_date] => 2017-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 20975 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15430123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14485109 [patent_doc_number] => 10329321 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-25 [patent_title] => Site-selective functionalization of proteins using traceless affinity labels [patent_app_type] => utility [patent_app_number] => 15/427678 [patent_app_country] => US [patent_app_date] => 2017-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 19190 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11729293 [patent_doc_number] => 20170190734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES' [patent_app_type] => utility [patent_app_number] => 15/423469 [patent_app_country] => US [patent_app_date] => 2017-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 130735 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15423469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11625895 [patent_doc_number] => 20170136084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'INHIBITORS OF IAP' [patent_app_type] => utility [patent_app_number] => 15/420817 [patent_app_country] => US [patent_app_date] => 2017-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10091 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15420817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15880281 [patent_doc_number] => 10646463 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-12 [patent_title] => Treatment for tumors driven by metabolic dysfunction [patent_app_type] => utility [patent_app_number] => 15/403675 [patent_app_country] => US [patent_app_date] => 2017-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 37167 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 453 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15403675 [rel_patent_id] =>[rel_patent_doc_number] =>)